trending Market Intelligence /marketintelligence/en/news-insights/trending/D22aqYdYo1kLSMjZlRoJpQ2 content esgSubNav
In This List

Madrigal Pharmaceuticals plans $100M common stock offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Madrigal Pharmaceuticals plans $100M common stock offering

Madrigal Pharmaceuticals Inc. is planning an underwritten public offering of $100 million worth of its common stock.

The company plans to grant the underwriters a 30-day option to buy up to an additional 15% of the shares offered.

Goldman Sachs & Co. LLC is the sole book runner of the offering.